Wolverine Trading’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-33,200	Closed	-$5.09M	–	7103
2021 Q1	$5.09M	Sell	33,200 -26,900	-45%	-$4.16M	0.01%	1095
2020 Q4	$9.39M	Buy	60,100 +8,500	+16%	+$1.09M	0.01%	713
2020 Q3	$5.8M	Sell	51,600 -13,700	-21%	-$1.48M	0.01%	776
2020 Q2	$7.26M	Sell	65,300 -6,800	-9%	-$722K	0.02%	612
2020 Q1	$6.29M	Buy	72,100 +17,700	+33%	+$1.74M	0.02%	641
2019 Q4	$5.84M	Sell	54,400 -8,900	-14%	-$952K	0.01%	990
2019 Q3	$6.19M	Buy	63,300 +18,900	+43%	+$2.13M	0.02%	747
2019 Q2	$5.82M	Buy	44,400 +25,400	+134%	+$3.27M	0.02%	795
2019 Q1	$2.57M	Sell	19,000 -5,600	-23%	-$696K	0.01%	1329
2018 Q4	$2.39M	Buy	24,600 +1,600	+7%	+$189K	0.01%	1283
2018 Q3	$3.2M	Sell	23,000 -56,100	-71%	-$7.04M	0.01%	1277
2018 Q2	$8.82M	Hold	79,100	–	–	0.02%	565
2018 Q1	$8.82M	Buy	+79,100	New	+$9.45M	0.02%	565
2017 Q4	–	Sell	-30,300	Closed	-$4.25M	–	5746
2017 Q3	$4.25M	Sell	30,300 -6,600	-18%	-$897K	0.02%	870
2017 Q2	$4.52M	Buy	36,900 +20,300	+122%	+$2.36M	0.02%	725
2017 Q1	$2.03M	Sell	16,600 -14,000	-46%	-$1.8M	0.01%	1181
2016 Q4	$3.74M	Buy	30,600 +7,100	+30%	+$869K	0.02%	905
2016 Q3	$2.82M	Buy	+23,500	New	+$3.02M	0.01%	1080